Literature DB >> 18343811

Proteasomes cleave at multiple sites within polyglutamine tracts: activation by PA28gamma(K188E).

Gregory Pratt1, Martin Rechsteiner.   

Abstract

Eukaryotic proteasomes have been reported to cleave only once within polyglutamine tracts and then only after the N-terminal glutamine (Venkatraman, P., Wetzel, R., Tanaka, M., Nukina, N., and Goldberg, A. L. (2004) Mol. Cell 14, 95-104). We have obtained results that directly conflict with that report. In the presence of the proteasome activator PA28gamma(K188E) human red cell proteasomes progressively degraded fluorescein-GGQ(10)RR or fluorescein-HPHQ(10)RR into small fragments as shown by size exclusion chromatography and mass spectrometry. MALDI-TOF mass spectrometry revealed that proteolytic products arose from cleavage after every glutamine in fluorescein-HPHQ(10)RR, and mass accuracy rules out deamidation of glutamine to glutamic acid as an explanation for peptide degradation. Moreover, degradation cannot be attributed to a contaminating protease because peptide hydrolysis was completely blocked by the proteasome-specific inhibitors, lactacystin and epoxomicin. We conclude that proteasomes cleave repetitively anywhere within a stretch of ten glutamine residues. Thus our results cast doubt on the idea that mammalian proteasomes cannot degrade glutamine-expanded regions within pathogenic polyQ-expanded proteins, such as Huntingtin.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18343811      PMCID: PMC2442343          DOI: 10.1074/jbc.M709347200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

1.  Polyglutamine-mediated aggregation and cell death.

Authors:  T de Cristofaro; A Affaitati; A Feliciello; E V Avvedimento; S Varrone
Journal:  Biochem Biophys Res Commun       Date:  2000-06-16       Impact factor: 3.575

2.  Polyglutamine disease and neuronal cell death.

Authors:  H L Paulson; N M Bonini; K A Roth
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

3.  Substrate specificity of the human proteasome.

Authors:  J L Harris; P B Alper; J Li; M Rechsteiner; B J Backes
Journal:  Chem Biol       Date:  2001-12

4.  Proteasomal-dependent aggregate reversal and absence of cell death in a conditional mouse model of Huntington's disease.

Authors:  E Martín-Aparicio; A Yamamoto; F Hernández; R Hen; J Avila; J J Lucas
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

5.  Impairment of the ubiquitin-proteasome system by protein aggregation.

Authors:  N F Bence; R M Sampat; R R Kopito
Journal:  Science       Date:  2001-05-25       Impact factor: 47.728

6.  Lysine 188 substitutions convert the pattern of proteasome activation by REGgamma to that of REGs alpha and beta.

Authors:  J Li; X Gao; J Ortega; T Nazif; L Joss; M Bogyo; A C Steven; M Rechsteiner
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

7.  Expanded polyglutamine peptides alone are intrinsically cytotoxic and cause neurodegeneration in Drosophila.

Authors:  J L Marsh; H Walker; H Theisen; Y Z Zhu; T Fielder; J Purcell; L M Thompson
Journal:  Hum Mol Genet       Date:  2000-01-01       Impact factor: 6.150

8.  Decreased expression of striatal signaling genes in a mouse model of Huntington's disease.

Authors:  R Luthi-Carter; A Strand; N L Peters; S M Solano; Z R Hollingsworth; A S Menon; A S Frey; B S Spektor; E B Penney; G Schilling; C A Ross; D R Borchelt; S J Tapscott; A B Young; J H Cha; J M Olson
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

9.  Structural basis for the activation of 20S proteasomes by 11S regulators.

Authors:  F G Whitby; E I Masters; L Kramer; J R Knowlton; Y Yao; C C Wang; C P Hill
Journal:  Nature       Date:  2000-11-02       Impact factor: 49.962

10.  Global changes to the ubiquitin system in Huntington's disease.

Authors:  Eric J Bennett; Thomas A Shaler; Ben Woodman; Kwon-Yul Ryu; Tatiana S Zaitseva; Christopher H Becker; Gillian P Bates; Howard Schulman; Ron R Kopito
Journal:  Nature       Date:  2007-08-09       Impact factor: 49.962

View more
  14 in total

Review 1.  Regulation of proteasome activity in health and disease.

Authors:  Marion Schmidt; Daniel Finley
Journal:  Biochim Biophys Acta       Date:  2013-08-27

2.  Differential degradation of full-length and cleaved ataxin-7 fragments in a novel stable inducible SCA7 model.

Authors:  Xin Yu; Abiodun Ajayi; Narasimha Rao Boga; Anna-Lena Ström
Journal:  J Mol Neurosci       Date:  2012-02-25       Impact factor: 3.444

3.  Dictyostelium discoideum has a highly Q/N-rich proteome and shows an unusual resilience to protein aggregation.

Authors:  Liliana Malinovska; Sandra Palm; Kimberley Gibson; Jean-Marc Verbavatz; Simon Alberti
Journal:  Proc Natl Acad Sci U S A       Date:  2015-05-04       Impact factor: 11.205

4.  Expanded polyglutamine-containing N-terminal huntingtin fragments are entirely degraded by mammalian proteasomes.

Authors:  Katrin Juenemann; Sabine Schipper-Krom; Anne Wiemhoefer; Alexander Kloss; Alicia Sanz Sanz; Eric A J Reits
Journal:  J Biol Chem       Date:  2013-08-01       Impact factor: 5.157

5.  A small-molecule Nrf1 and Nrf2 activator mitigates polyglutamine toxicity in spinal and bulbar muscular atrophy.

Authors:  Laura C Bott; Nisha M Badders; Ke-Lian Chen; George G Harmison; Elaine Bautista; Charles C-Y Shih; Masahisa Katsuno; Gen Sobue; J Paul Taylor; Nico P Dantuma; Kenneth H Fischbeck; Carlo Rinaldi
Journal:  Hum Mol Genet       Date:  2016-03-08       Impact factor: 6.150

6.  Sequence- and species-dependence of proteasomal processivity.

Authors:  Daniel A Kraut; Eitan Israeli; Erin K Schrader; Ashwini Patil; Kenta Nakai; Dhaval Nanavati; Tomonao Inobe; Andreas Matouschek
Journal:  ACS Chem Biol       Date:  2012-06-28       Impact factor: 5.100

Review 7.  Intracellular degradation of misfolded proteins in polyglutamine neurodegenerative diseases.

Authors:  Xiang Li; He Li; Xiao-Jiang Li
Journal:  Brain Res Rev       Date:  2008-08-23

8.  The Ubiquitin-Proteasome System in Huntington's Disease: Are Proteasomes Impaired, Initiators of Disease, or Coming to the Rescue?

Authors:  Sabine Schipper-Krom; Katrin Juenemann; Eric A J Reits
Journal:  Biochem Res Int       Date:  2012-09-24

9.  Misfolding of proteins with a polyglutamine expansion is facilitated by proteasomal chaperones.

Authors:  Erwann Rousseau; Rieko Kojima; Guylaine Hoffner; Philippe Djian; Anne Bertolotti
Journal:  J Biol Chem       Date:  2008-11-05       Impact factor: 5.157

10.  The ubiquitin-proteasome reporter GFPu does not accumulate in neurons of the R6/2 transgenic mouse model of Huntington's disease.

Authors:  John S Bett; Casey Cook; Leonard Petrucelli; Gillian P Bates
Journal:  PLoS One       Date:  2009-04-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.